ARTLVSNRSN• 6 Months (Normalized)
ARTL vs NRSN (Artelo Biosciences Inc. vs NeuroSense Therapeutics Ltd.)
Showing Closing Date Range from Apr 3 to Sep 30, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ARTL Performance $4.54
+%
Artelo Biosciences Inc.
Normalized Baseline0.00%
NRSN Performance $4.78
+527.3%
NeuroSense Therapeutics Ltd.
Normalized Baseline0.00%
Alpha Spread Margin NRSN LEADS
-527.3 pts
NRSN outperforming by 527.30 percentage points
ARTLNRSN
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ARTL NRSN
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(123 dates)
| Date | ARTL Price | ARTL Gain (%) | NRSN Price | NRSN Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 29, 2026 | $- | $4.78 | +527.30% | - | |
| Sep 28, 2026 | $- | $5.10 | +569.29% | - | |
| Sep 25, 2026 | $4.54 | -92.37% | $6.95 | +812.07% | -904.44% |
| Sep 24, 2026 | $5.17 | -91.31% | $7.40 | +871.13% | -962.44% |
| Sep 23, 2026 | $7.31 | -87.71% | $7.40 | +871.13% | -958.84% |
| Sep 22, 2026 | $4.15 | -93.02% | $7.18 | +842.26% | -935.28% |
| Sep 21, 2026 | $4.10 | -93.11% | $6.62 | +768.77% | -861.88% |
| Sep 18, 2026 | $3.94 | -93.38% | $6.35 | +733.33% | -826.71% |
| Sep 17, 2026 | $3.97 | -93.33% | $6.72 | +781.89% | -875.22% |
| Sep 16, 2026 | $3.75 | -93.70% | $6.49 | +751.71% | -845.41% |
| Sep 15, 2026 | $5.34 | -91.02% | $7.03 | +822.57% | -913.59% |
| Sep 14, 2026 | $4.87 | -91.81% | $6.90 | +805.51% | -897.32% |
| Sep 11, 2026 | $5.43 | -90.87% | $0.35 | -54.46% | -36.41% |
| Sep 10, 2026 | $5.63 | -90.54% | $0.33 | -56.43% | -34.11% |
| Sep 09, 2026 | $5.98 | -89.95% | $0.40 | -47.38% | -42.57% |
Page 1 of 9